A citation-based method for searching scientific literature

Thuy Thi Lai, Yun Joong Kim, Hyeo-Il Ma, Young Eun Kim. J Mov Disord 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.
M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone, W D Cash. J Pharmacol Exp Ther 1987
113
50

Dangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway.
Rui-Rui Ding, Wang Chen, Cong-Ying Guo, Wei-Tao Liao, Xia Yang, Feng-Er Liao, Jing-Ming Lin, Han-Fang Mei, Yu Zeng. Biomed Pharmacother 2018
10
50

Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
Robert A Hauser, Fabrizio Stocchi, Olivier Rascol, Susan B Huyck, Rachel Capece, Tony W Ho, Peter Sklar, Christopher Lines, David Michelson, David Hewitt. JAMA Neurol 2015
66
50

Xanthines as adenosine receptor antagonists.
Christa E Müller, Kenneth A Jacobson. Handb Exp Pharmacol 2011
79
50

Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons.
Tobias Weinert, Natacha Olieric, Robert Cheng, Steffen Brünle, Daniel James, Dmitry Ozerov, Dardan Gashi, Laura Vera, May Marsh, Kathrin Jaeger,[...]. Nat Commun 2017
121
50

Pharmacology of Adenosine Receptors: The State of the Art.
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, Fabrizio Vincenzi, Katia Varani. Physiol Rev 2018
312
50

Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson's disease.
Peter Jenner, Akihisa Mori, Stephen D Aradi, Robert A Hauser. Expert Rev Neurother 2021
21
50

Interleukin-1 and neuronal injury.
Stuart M Allan, Pippa J Tyrrell, Nancy J Rothwell. Nat Rev Immunol 2005
729
50

Antioxidant and Anti-Inflammatory Profiles of Spent Coffee Ground Extracts for the Treatment of Neurodegeneration.
Simone Angeloni, Michela Freschi, Pasquale Marrazzo, Silvana Hrelia, Daniela Beghelli, Ana Juan-García, Cristina Juan, Giovanni Caprioli, Gianni Sagratini, Cristina Angeloni. Oxid Med Cell Longev 2021
5
50

A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
Annalisa Pinna, Elisabetta Tronci, Nicoletta Schintu, Nicola Simola, Rosaria Volpini, Silvia Pontis, Gloria Cristalli, Micaela Morelli. Neuropharmacology 2010
33
50

Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity.
Robert K Y Cheng, Elena Segala, Nathan Robertson, Francesca Deflorian, Andrew S Doré, James C Errey, Cédric Fiez-Vandal, Fiona H Marshall, Robert M Cooke. Structure 2017
125
50

Recent developments in adenosine receptor ligands and their potential as novel drugs.
Christa E Müller, Kenneth A Jacobson. Biochim Biophys Acta 2011
295
50

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.
Bertil B Fredholm, Adriaan P IJzerman, Kenneth A Jacobson, Joel Linden, Christa E Müller. Pharmacol Rev 2011
928
50


The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
Veli-Pekka Jaakola, Mark T Griffith, Michael A Hanson, Vadim Cherezov, Ellen Y T Chien, J Robert Lane, Adriaan P Ijzerman, Raymond C Stevens. Science 2008
50


Development and validation of a genetic algorithm for flexible docking.
G Jones, P Willett, R C Glen, A R Leach, R Taylor. J Mol Biol 1997
50

M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation.
Shinji Oishi, Ryosuke Takano, Satoshi Tamura, Shinya Tani, Moriya Iwaizumi, Yasushi Hamaya, Kosuke Takagaki, Toshi Nagata, Shintaro Seto, Toshinobu Horii,[...]. Immunology 2016
59
50

Regulation of inflammation by adenosine.
György Haskó, Bruce Cronstein. Front Immunol 2013
216
50

Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor.
Diego Dal Ben, Michela Buccioni, Catia Lambertucci, Ajiroghene Thomas, Rosaria Volpini. In Silico Pharmacol 2013
21
50

NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes.
Audrey Gustin, Mélanie Kirchmeyer, Eric Koncina, Paul Felten, Sophie Losciuto, Tony Heurtaux, Aubry Tardivel, Paul Heuschling, Catherine Dostert. PLoS One 2015
223
50

The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.
Katja Badanjak, Sonja Fixemer, Semra Smajić, Alexander Skupin, Anne Grünewald. Int J Mol Sci 2021
35
50


Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction.
Nelson Rebola, Ana Patrícia Simões, Paula M Canas, Angelo R Tomé, Geanne M Andrade, Claire E Barry, Paula M Agostinho, Marina A Lynch, Rodrigo A Cunha. J Neurochem 2011
141
50

Molecular modeling study on potent and selective adenosine A(3) receptor agonists.
Diego Dal Ben, Michela Buccioni, Catia Lambertucci, Gabriella Marucci, Ajiroghene Thomas, Rosaria Volpini, Gloria Cristalli. Bioorg Med Chem 2010
26
50

Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
Kenneth A Jacobson, Adriaan P IJzerman, Christa E Müller. Biochem Pharmacol 2021
20
50

9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities.
Karl-Norbert Klotz, Sonja Kachler, Catia Lambertucci, Sauro Vittori, Rosaria Volpini, Gloria Cristalli. Naunyn Schmiedebergs Arch Pharmacol 2003
33
50

Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17.
Michela Buccioni, Gabriella Marucci, Diego Dal Ben, Dania Giacobbe, Catia Lambertucci, Laura Soverchia, Ajiroghene Thomas, Rosaria Volpini, Gloria Cristalli. Purinergic Signal 2011
37
50


Adenosine receptors as therapeutic targets.
Kenneth A Jacobson, Zhan-Guo Gao. Nat Rev Drug Discov 2006
50

Adenosine and inflammation: it's time to (re)solve the problem.
Luca Antonioli, Pál Pacher, György Haskó. Trends Pharmacol Sci 2022
7
50

Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.
Hui-Ming Gao, Janwei Jiang, Belinda Wilson, Wanqin Zhang, Jau-Shyong Hong, Bin Liu. J Neurochem 2002
516
50

The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant.
Peter A LeWitt, Stephen D Aradi, Robert A Hauser, Olivier Rascol. Parkinsonism Relat Disord 2020
17
50


The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation.
Anja Henn, Søren Lund, Maj Hedtjärn, Andreé Schrattenholz, Peter Pörzgen, Marcel Leist. ALTEX 2009
469
50

Macrophage plasticity and polarization: in vivo veritas.
Antonio Sica, Alberto Mantovani. J Clin Invest 2012
50

CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease.
Yuejun Wang, Li Li, Yuting Wu, Shouping Zhang, Qianqian Ju, Yinuo Yang, Yan Jin, Hui Shi, Cheng Sun. Pharmacol Res 2022
2
50

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.
Franz G Bauernfeind, Gabor Horvath, Andrea Stutz, Emad S Alnemri, Kelly MacDonald, David Speert, Teresa Fernandes-Alnemri, Jianghong Wu, Brian G Monks, Katherine A Fitzgerald,[...]. J Immunol 2009
50

New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity.
Catia Lambertucci, Andrea Spinaci, Michela Buccioni, Diego Dal Ben, Michael Alliance Ngouadjeu Ngnintedem, Sonja Kachler, Gabriella Marucci, Karl-Norbert Klotz, Rosaria Volpini. Bioorg Chem 2019
3
50

Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease.
Souvarish Sarkar, Emir Malovic, Dilshan S Harishchandra, Shivani Ghaisas, Nikhil Panicker, Adhithiya Charli, Bharathi N Palanisamy, Dharmin Rokad, Huajun Jin, Vellareddy Anantharam,[...]. NPJ Parkinsons Dis 2017
136
50

Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists.
Pei Shang, Matthew Baker, Samantha Banks, Sa-Ik Hong, Doo-Sup Choi. J Mov Disord 2021
4
50

Adenosine, adenosine A 2A antagonists, and Parkinson's disease.
P Jenner, A Mori, R Hauser, M Morelli, B B Fredholm, J F Chen. Parkinsonism Relat Disord 2009
147
50

Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor.
Diego Dal Ben, Michela Buccioni, Catia Lambertucci, Gabriella Marucci, Claudia Santinelli, Andrea Spinaci, Ajiroghene Thomas, Rosaria Volpini. Mol Inform 2016
7
50

New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists.
Matteo Falsini, Costanza Ceni, Daniela Catarzi, Flavia Varano, Diego Dal Ben, Gabriella Marucci, Michela Buccioni, Aleix Martí Navia, Rosaria Volpini, Vittoria Colotta. Bioorg Med Chem Lett 2020
3
50

A2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders.
Catia Lambertucci, Gabriella Marucci, Daniela Catarzi, Vittoria Colotta, Beatrice Francucci, Andrea Spinaci, Flavia Varano, Rosaria Volpini. Curr Med Chem 2022
1
100

Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists.
Aleix Martí Navia, Diego Dal Ben, Catia Lambertucci, Andrea Spinaci, Rosaria Volpini, Inês Marques-Morgado, Joana E Coelho, Luísa V Lopes, Gabriella Marucci, Michela Buccioni. Cells 2020
16
50

Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials.
Robert A Hauser, Nobutaka Hattori, Hubert Fernandez, Stuart H Isaacson, Hideki Mochizuki, Olivier Rascol, Fabrizio Stocchi, June Li, Akihisa Mori, Yu Nakajima,[...]. J Parkinsons Dis 2021
9
50

Crystal structure refinement with SHELXL.
George M Sheldrick. Acta Crystallogr C Struct Chem 2015
50

Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease.
Stefka Gyoneva, Lauren Shapiro, Carlos Lazo, Ethel Garnier-Amblard, Yoland Smith, Gary W Miller, Stephen F Traynelis. Neurobiol Dis 2014
70
50

[3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
Karl-Norbert Klotz, Nico Falgner, Sonja Kachler, Catia Lambertucci, Sauro Vittori, Rosaria Volpini, Gloria Cristalli. Eur J Pharmacol 2007
51
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.